Hotchkis & Wiley Capital Management Adds $54M in Elevance Health, Inc. ($ELV)

Key Points

  • Hotchkis & Wiley Capital Management changed its Elevance Health, Inc. ($ELV) stake by 6.85% last quarter, boosting to 2,191,563 shares worth $846.69 million.
  • Wall Street's consensus rating on $ELV is Buy and an average price target of $449.10.
  • $ELV last traded around $386.34.

Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.

Hotchkis & Wiley Capital Management increased its position in Elevance Health, Inc. ($ELV) by 6.85% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,191,563 shares of Elevance Health, Inc. after buying 140,413 shares during the quarter. Hotchkis & Wiley Capital Management's holdings in Elevance Health, Inc. were worth $846.69 million as of its most recent filing.

Elevance Health, Inc. Stock Down 2.1%

Shares of Elevance Health, Inc. ($ELV) traded around $386.34 on Saturday, down 2.1% for the day.

Last price$386.34
Market cap$85.13B
P/E ratio17.37
Forward P/E13.26
PEG ratio1.40
Beta0.69
52-week low$274.84
52-week high$436.24
50-day MA$394.81
200-day MA$357.29
Current ratio1.52
Quick ratio1.37
Debt-to-equity0.69

Elevance Health, Inc. Earnings

EPS (ttm)$22.60
Revenue (ttm)$201.11B
Revenue growth1.40%
Net margin2.47%
Return on equity11.13%
Next earningsOct 21, 2026

Elevance Health, Inc. Dividend

Annual dividend$6.88
Dividend yield174%
Payout ratio30.34%
Ex-dividend dateSep 10, 2026

Analysts Set New Price Targets

ConsensusBuy
Average target$449.10
High target$492
Low target$393
Analysts covering21

About Elevance Health, Inc.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

ExchangeNYSE
SectorHealthcare
IndustryHealthcare Plans
HeadquartersIndianapolis, IN
CEOMs. Gail Koziara Boudreaux
Employees96,129

Get Elevance Health, Inc. alerts

New 13F filings, insider trades, and analyst moves on $ELV, sent to your inbox. Free, and you can unsubscribe anytime.

This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.